Início › Câncer de Ovário › Utah
Ensaios clínicos de Câncer de Ovário em Utah
29 estudos para Câncer de Ovário estão buscando participantes em locais em Utah.
Cidades em Utah
Texto oficial do estudo (Inglês)
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
- Start Mountain Region /ID# 278609, West Valley City
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07278336A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Intermountain Health, Salt Lake City
RecrutandoFase 1
Idades 19 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06586957A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Huntsman Cancer Institute, Salt Lake City
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07213804A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- START Center for Cancer Research, West Valley City
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07109726A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Utah Cancer Specialists, Salt Lake City
RecrutandoFase 2
Idades de 18 a 99 · Mulheres · Atualizado em 15 de set. de 2026 · NCT07023627ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Utah Cancer Specialists, Salt Lake City
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- START Mountain Region, West Valley City
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT06303505A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- START Mountain Region, West Valley City
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06400472A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University of Utah - Huntsman Cancer Institute, Salt Lake City
- START Mountain Region, West Valley City
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06465069A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Intermountain/LDS Hospital Ph 1 Research Program, Salt Lake City
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06774963Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- Huntsman Cancer Institute/University of Utah, Salt Lake City
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT07001748A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
- START Mountain, Salt Lake City
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07470853Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 13 de ago. de 2026 · NCT05985655A Study of MGC026 in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT06242470A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Recrutando
Idades de 35 a 50 · Mulheres · Atualizado em 7 de ago. de 2026 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- South Jordan Health Center, South Jordan
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT06580314A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Huntsman Cancer Institute, University of Utah, Salt Lake City
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT06330064Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- START Mountain Region, West Valley City
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 4 de ago. de 2026 · NCT05579366A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START Mountain Region, West Valley City
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT06270706A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Utah Cancer Specialists, Salt Lake City
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT04657068First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT05768139Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Utah Cancer Specialists Network, Salt Lake City
RecrutandoFase 3
Idades 18 e acima · Mulheres · Atualizado em 2 de jul. de 2026 · NCT06819007A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Huntsman Cancer Institute, Salt Lake City
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT05377996Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
- START Mountain Region, West Valley City
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT07517198Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 30 de abr. de 2026 · NCT05297734The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer
- Huntsman Cancer Institute, Salt Lake City
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades 21 e acima · Mulheres · Atualizado em 9 de abr. de 2026 · NCT06665945A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- START Center for Cancer Care - Mountain Region, Salt Lake City
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 27 de mar. de 2026 · NCT06395519A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
- LDS Hospital, Salt Lake City
RecrutandoFase 1
Idades 18 e acima · Mulheres · Atualizado em 3 de fev. de 2026 · NCT06469281SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Salt Lake City
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.